tiprankstipranks
Trending News
More News >

TYK Medicines Announces Board and Committee Roles

Story Highlights
TYK Medicines Announces Board and Committee Roles

Don’t Miss TipRanks’ Half-Year Sale

TYK Medicines, Inc. Class H ( (HK:2410) ) has issued an update.

TYK Medicines, Inc., a joint stock company incorporated in the People’s Republic of China, has announced the composition of its board of directors and their respective roles within the company’s committees. This announcement provides clarity on the leadership structure of the company, indicating the members and chairpersons of the Audit, Remuneration and Appraisal, Nomination, and Scientific Committees, which could impact the company’s governance and strategic direction.

The most recent analyst rating on (HK:2410) stock is a Buy with a HK$31.60 price target. To see the full list of analyst forecasts on TYK Medicines, Inc. Class H stock, see the HK:2410 Stock Forecast page.

More about TYK Medicines, Inc. Class H

Average Trading Volume: 2,203,797

Technical Sentiment Signal: Strong Sell

Current Market Cap: HK$8.22B

For detailed information about 2410 stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1